Long-term Prognosis of Patients with Cardiac Syndrome X: a Review
Overview
Affiliations
Aims: Follow-up studies of patients with cardiac syndrome X (CSX) generally report good prognosis. However, some recent studies report an adverse outcome for women.
Methods And Results: Structured literature search and meta-analysis for studies regarding prognosis of cardiac syndrome X patients. We identified 85 studies, ultimately selecting 16 for inclusion. Meta-analysis yielded a pooled major cardiac event percentage of 1.5% per 5 years and a pooled vascular event percentage of 4.8% per 5 years (n = 16 studies, n = 1694 patients). Fourteen studies reported upon the recurrence rate of angina pectoris: the pooled percentage of angina recurrence was 55% (n = 1336 patients).
Conclusion: The present review of recent archival literature demonstrates an overall major cardiac event rate of 1.5% per 5 years. Although this is an excellent prognosis for CSX patients, the quality of life is impaired because of the high recurrence rate of angina pectoris (55%).
Coronary Microvascular Dysfunction and the Role of Noninvasive Cardiovascular Imaging.
Ayub M, Kalra D Diagnostics (Basel). 2020; 10(9).
PMID: 32916881 PMC: 7555249. DOI: 10.3390/diagnostics10090679.
Non-pharmacological Treatment of Refractory Angina and Microvascular Angina.
Rakhimov K, Gori T Biomedicines. 2020; 8(8).
PMID: 32823683 PMC: 7460172. DOI: 10.3390/biomedicines8080285.
Iyngkaran P, Chan W, Liew D, Zamani J, Horowitz J, Jelinek M World J Methodol. 2019; 9(1):1-19.
PMID: 30705870 PMC: 6354077. DOI: 10.5662/wjm.v9.i1.1.
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z.
Sciacchitano S, Lavra L, Morgante A, Ulivieri A, Magi F, De Francesco G Int J Mol Sci. 2018; 19(2).
PMID: 29373564 PMC: 5855601. DOI: 10.3390/ijms19020379.
Mejia-Renteria H, van der Hoeven N, van de Hoef T, Heemelaar J, Ryan N, Lerman A Int J Cardiovasc Imaging. 2017; 33(7):1041-1059.
PMID: 28501910 DOI: 10.1007/s10554-017-1136-9.